Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Cartridge-Based E-Cigarettes on Cardiopulmonary Health
NCT05199480Phase 1Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jan 2022
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by Virginia Commonwealth University. Primary endpoints: Peak Oxygen Consumption at 2 weeks and Expiratory Volume at 2 weeks. Started Jan 2022; status: completed.
Beyond the preview
Go deeper on NCT05199480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199480.